RadNet Inc. (NASDAQ:RDNT) Director John V. Crues sold 20,000 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $10.08, for a total transaction of $201,600.00. Following the completion of the transaction, the director now directly owns 563,781 shares of the company’s stock, valued at approximately $5,682,912.48. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
RadNet Inc. (NASDAQ RDNT) opened at $10.10 on Monday. RadNet Inc. has a 1-year low of $5.25 and a 1-year high of $11.90. The company has a market cap of $481.00, a PE ratio of 33.67, a price-to-earnings-growth ratio of 3.39 and a beta of 0.82. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 7.88.
RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Thursday, November 9th. The medical research company reported $0.12 EPS for the quarter, meeting the consensus estimate of $0.12. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The business had revenue of $227.60 million during the quarter, compared to the consensus estimate of $232.84 million. During the same quarter in the prior year, the firm earned $0.11 EPS. The business’s revenue was up 1.3% on a year-over-year basis. equities research analysts forecast that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.
Several research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of RadNet from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. TheStreet downgraded shares of RadNet from a “b-” rating to a “c” rating in a report on Friday, October 27th. BidaskClub raised shares of RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, Jefferies Group raised shares of RadNet from a “hold” rating to a “buy” rating and upped their target price for the stock from $7.00 to $12.00 in a report on Tuesday, August 22nd.
ILLEGAL ACTIVITY WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/04/radnet-inc-rdnt-director-sells-201600-00-in-stock.html.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
What are top analysts saying about RadNet Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RadNet Inc. and related companies.